Barriers keep drug makers out of the market
239493
The shortage of flu vaccines this season should serve as a wake-up call about the serious challenges facing the vaccine business and the resulting threat to public health.
18004
THE US pharmaceutical industry that exports medicines around the world is facing further scrutiny after a survey revealed nearly one-fifth of its government overseers had experienced pressure to approve drugs about which they had reservations.
226597
A shortage of laboratory apes and monkeys could be holding back research into new drug treatments and genetics, it is claimed.
158802
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
266391
The pharmaceutical industry, fighting to defeat proposals that would give U.S. patients easier access to cheaper Canadian drugs, is making the most of its chance for face time with lawmakers at the GOP convention.
468484
Importing cheaper drugs from up north isn't as simple as it seems
378482
These products don't come without serious risks.
232471
BRUSSELS, Oct 30  (IPS) - The struggle to make medicines affordable to the  worldâs poor, especially in Africa, is raging on at the highest  levels. Last week the European Commission took a landmark  decision on generic drugs and next week a high-level  intergovernmental meeting will look at ways to prevent patents  from blocking access to drugs.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
544741
The pharmaceutical market is failing to conceive of new pregnancy medication, creating just three drug patents for maternal health in 28 years, British researchers said on Tuesday.
174211
A drug manufacturer has been found to infringe patents licensed by the maker of a rival drug.
2756
NEW YORK - The pharmaceutical industry has endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration were expected to take a more cautious approach
274301
OTTAWA (CP) - Admitting that drug patent regulations are unclear and subject to abuse, Ottawa is returning the rules governing competition between brand-name and generic drug makers.
632263
Late-stage drugs are crucial for a company beset with patent losses.
610018
New technology could lead to safer, more effective drugs.
575599
Patients losing their sight say they are being denied access to a drug which could stop them from going blind.